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Synopsis 
 
The transcription factor hypoxia inducible factor (HIF) mediates a highly pleiotrophic 
response to hypoxia. Many recent studies have focused on defining the extent of this 
transcriptional response. Here we have analysed regulation by hypoxia amongst 
transcripts encoding human Fe(II) and 2-oxoglutarate dependent oxygenases. Our 
results show that many of these genes are regulated by hypoxia and define two groups 
of Jumonji-domain containing histone demethylases as new classes of hypoxia regulated 
gene. Patterns of induction were consistent across a range of cell lines with JMJD1A 
and JMD2B demonstrating robust, and JMJD2C more modest, upregulation by 
hypoxia. Functional genetic and chromatin immunoprecipitation studies demonstrated 
the importance of HIF-1alpha in mediating these responses. Given the importance of 
histone methylation status in defining patterns of gene expression under different 
physiological and pathophysiological conditions these findings predict a role for the HIF 
system in epigenetic regulation. 
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Introduction 
 
Hypoxia is a major component of many human diseases and induces a range of cellular and systemic 
responses that function to restore oxygen homeostasis or better adapt cells to the hypoxic 
environment. At the cellular level these responses include regulation of fundamental physiological 
processes such as energy metabolism, proliferation, apoptosis, motility, and differentiation (for 
review, see [1, 2]).  
 
Important insights into these processes have been gained though the definition of hypoxia signaling 
pathways that regulate gene expression in accordance with cellular oxygen availability. Hypoxia 
inducible factor (HIF) is an alpha/beta heterodimeric transcription factor that binds DNA at hypoxia 
response elements (HREs) associated with its transcriptional target genes [1]. HIF itself is regulated 
by post-translational hydroxylation of specific residues in its alpha subunits by a set of Fe(II) and 2-
oxoglutarate (2OG)-dependent oxygenases [3, 4]. In the presence of oxygen, hydroxylation (catalysed 
by three closely related prolyl hydroxylase domain enzymes, PHD1, 2 and 3) at two prolyl-residues 
promotes binding of HIF-alpha subunits to the von Hippel-Lindau tumor suppressor (pVHL) E3 
ubiquitin ligase leading to proteasomal degradation (for review see [5]). In hypoxia, these reactions 
are suppressed allowing the assembly of an active HIF complex and induction of a range of genes that 
respond directly or indirectly to HIF. 
 
Recent work has sought to better define the extent of this transcriptional cascade, with studies 
demonstrating both an extensive set of direct HIF transcriptional target genes, and indirect effects 
through the induction of regulatory molecules that themselves influence gene expression [6, 7]. Pan-
genomic assays of transcript abundance have emphasized the overall importance of the HIF 
hydroxylase system in defining patterns of hypoxia inducible gene expression and have revealed 
many new and important hypoxia-inducible genes [8-10]. In the main, such analyses have focused on 
defining statistically robust induction of specific genes rather than interrogating patterns of response 
among specific families encoding functionally or structurally related proteins.  
 
Of particular interest in this respect is the 2OG dependent oxygenase superfamily itself. In addition to 
2OG dependent oxygenases that function in cellular oxygen sensing, the family encompasses 
members with diverse functions including post-translational modification of proteins (e.g. collagen 
stabilization), fatty acid metabolism and DNA repair [11-13]. Since all 2OG dependent oxygenases 
have an obligatory requirement for dioxygen as co-substrate, the activity of some of these enzymes in 
cells may be affected by the extracellular oxygen status. Several 2OG dependent oxygenases, 
including two of the HIF hydroxylases have been identified as hypoxia-inducible gene products [14-
17]. 
 
Bioinformatic analyses have predicted that the human genome encodes in excess of sixty 2OG 
dependent dioxygenases Though the functions of many remain unassigned, a number have recently 
been demonstrated to function in histone modification, particularly histone lysine and arginyl 
demethylation [18, 19]. 
 
To investigate patterns of induction by hypoxia we assembled a refined compilation of human 2OG-
dependent oxygenases, reanalyzed microarray-based transcriptome profiling of the MCF7 breast 
cancer cell line in normoxic and hypoxic conditions [10], and tested the role of the HIF system in such 
responses using a series of genetic interventions on the HIF pathway. The results define genes 
encoding the JmjC-domain-containing histone demethylases (JMJDs) as a new class of gene regulated 
by the HIF system and demonstrate consistent patterns of induction by HIF-1alpha amongst different 
family members. 
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Experimental 
 
Cell culture  
 
Human oesteosarcoma (U2OS), human breast cancer (MCF7) and human cervical carcinoma (HeLa) 
cells were cultured in Dulbecco's modified Eagle medium (DMEM) (Invitrogen) supplemented with 
10% (v/v) fetal calf serum (FCS) (Sigma). Human neuroblastoma cells (IMR 32) were cultured in 
Eagle's minimal essential medium (Invitrogen) with 10% (v/v) FCS, 2mM glutamine (Invitrogen) and 
non-essential amino acids. Human promyelocytic leukemia (HL60) cells were grown in RPMI 
(Invitrogen) with 15% (v/v) FCS. All cells were maintained in a humidified atmosphere of 5% CO2 
and 21% O2. Both R38 (human renal carcinoma (RCC4) cells that express a tetracycline-inducible 
hemaglutinin (HA)-tagged VHL transgene) and C29 (U2OS cells expressing tetracycline inducible 
HIF-1alpha) have been previously described [20, 21] and were cultured in DMEM with 10% (v/v) 
tetracycline-free FCS (BD Bioscience) supplemented with 1μg/ml G418 and 5μg/ml Blasticidin 
(Sigma). In the experimental work, cells were cultured under normoxic conditions (5% CO2, 21% O2) 
or in hypoxia (16 hours at 5% CO2, 0.5% O2). Where specified, cells were treated with 
dimethyloxalylglycine (DMOG) (1 mM for 16 hours) or desferrioxamine (DFO) (100μM for 16 
hours). 
siRNA Treatment of Cells 
MCF7 and U2OS cells were seeded at 30% confluency and grown in normoxic conditions. Cells were 
transfected with siRNA (20nM) using Oligofectamine (Invitrogen) according to the manufacturer’s 
protocol. After 24 hours the cells were transfected again and exposed to hypoxia for 16 hours after 
which they were washed, lysed and RNA and protein was extracted. The siRNA oligonucleotide 
sequences used were as previously described [22]. 
RNA Extraction and cDNA synthesis 
 
Total RNA was extracted using the Sigma Total RNA kit (Sigma) according to the manufacturer’s 
protocol. First strand cDNA synthesis was generated from 5μg of total RNA (GE Healthcare). 
 
Protein Extraction and Immunoblot Analysis 
 
Preparation of cell extracts and immunoblot analyses were performed as described previously [23]. 
Primary antibodies used were mouse anti-HIF-1alpha (BD Transduction Laboratories), rabbit anti-
HIF-2alpha (Novus Biologicals), rabbit anti-JMJD1A (Abcam), mouse horseradish peroxidase (HRP)-
conjugated anti-HA (Dako) and mouse HRP-conjugated anti-actin (Abcam). 
 
Chromatin Immunoprecipitation (ChIP) Assays 
 
Chromatin immunoprecipitation assays were performed using a modified version of the Upstate 
Protocol (Millipore). In brief, MCF7 cells were incubated with 2mM DMOG for 16 hours to increase 
HIF-alpha levels. DNA-binding proteins were cross-linked to DNA using formaldehyde at a final 
concentration of 1% (w/v) for 10 minutes at 25oC, followed by treatment with glycine (125mM) for a 
further 5 minutes. Cells were washed in PBS, lysed in SDS lysis buffer, and sonicated (Sonics & 
Materials, VCX 500). The supernatant was collected by centrifugation and pre-cleared with protein A 
agarose beads (Millipore). Chromatin was then incubated overnight with rabbit polyclonal anti-sera to 
HIF-1alpha (PM14) and HIF-2alpha (PM9) [24] before adding protein A agarose for a further hour. 
Pre-immune serum was used as a negative control. The beads were washed and immunoprecipitated 
complexes were eluted into 1% SDS, 0.1 M sodium bicarbonate elution buffer. Cross-linking was 
reversed by overnight incubation at 65oC and followed by protein digestion with proteinase K. DNA 
was recovered by phenol/chloroform extraction and ethanol precipitation. 
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Real-time quantitative PCR 
 
RT-Q-PCR for mRNA quantification employed Taqman gene expression assays on a StepOne 
thermocycler (Applied Biosystems). Normalization was to β-actin mRNA and relative gene 
expression was calculated using the ΔΔCT method. 50 ng of cDNA template per reaction was used 
and 3 biological replicates, each in triplicate, were performed for each experiment. For quantification 
of HIF binding sites, ChIP DNA (5 ng) from each of input, preimmune sera, PM14 and PM9 was 
subject to RT-Q-PCR using oligonucleotides designed to amplify putative HRE consensus sequences 
(supplementary data). Fold enrichment of each HRE in the DMOG treated cells was determined by 
the ΔΔCT method. 
 
Statistical analysis 
 
Statistically comparisons were performed using Student’s unpaired t-test. 
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Results 
 
The human genome encodes multiple sub-groups of 2-OG dependent oxygenases that are 
regulated by hypoxia 
 
Using structurally informed sequence analysis coupled to functional knowledge, we grouped known 
or predicted 2OG dependent oxygenases into subfamilies, and defined the existence or otherwise of 
regulation by hypoxia by reference to comparative whole genome expression arrays [10] conducted 
on normoxic and hypoxic MCF7 cells (Table 1). The data indicated that some, but not all transcripts 
are substantially up-regulated in hypoxic cells. Reported patterns of induction by hypoxia were 
confirmed for several subfamilies of enzyme, including the HIF prolyl hydroxylases (PHDs), the pro-
collagen prolyl hydroxylases (C-P4Hs) and the pro-collagen lysyl hydroxylases (PLODs) [4, 14-17]. 
In addition several other classes of 2OG dependent oxygenases contained members that manifest 
significant upregulation by hypoxia. Particularly striking was the upregulation of transcripts encoding 
the Jumonji domain containing proteins JMJD1A and JMJD2B. These proteins belong to the JMJD1 
(otherwise known as JHDM2 and containing JmjC and modified zinc-finger domains) and JMJD2 
(otherwise known as JHDM3 and containing JmjC, JmjN, plant homology domains and Tudor 
domains) subfamilies of 2OG dependent oxygenase that have recently been demonstrated to possess 
histone lysyl demethylase (HDM) activity [18, 25, 26]. To better define this new class of hypoxia-
regulated gene we performed further experiments on seven members (JMJD1A-C; JMJD2A-D) of 
these families that have been definitively assigned as possessing HDM activity.  
 
First, to verify the results of the micro-array analysis and to determine whether regulation by hypoxia 
was manifested in different cell types, expression of all seven transcripts was analysed by real-time 
quantitative PCR (RT-Q-PCR) in a panel of cell lines. MCF7, U2OS, HeLa, IMR32 and HL60 cells 
were exposed to hypoxia (0.5% O2 for 16 hours). Consistent patterns of induction by hypoxia were 
observed across all five cell lines (Figure 1a). Much the most striking induction by hypoxia was 
observed for JMJD1A (ranging from 2.6-4.7 fold) and JMJD2B mRNA (ranging from 2.5-4.6 fold) 
(Figure 1a). Other family members did not manifest induction by hypoxia, with the exception of 
JMJD2C which manifested modest (up to 2-fold) induction in some cell types.  
 
Regulation of genes encoding Jumonji domain containing proteins JMJD1 and JMJD2 by the 
HIF hydroxylase pathway 
 
Inspection of the microarray data indicated that genes manifesting induction by hypoxia were also 
commonly induced by dimethyloxalylglycine (DMOG) a cell-penetrating competitive inhibitor of 
many 2OG oxygenases including the hydroxylases that regulate HIF [4]. To pursue the potential role 
of HIF hydroxylase pathways in the regulation of genes encoding JMJD1 and JMJD2 family 
members, we extended this analysis to other cell types, and tested responses to both DMOG (1mM for 
16 hours) and desferrioxamine (DFO, 100μM for 16 hours), another agent that upregulates HIF by 
inhibition of 2OG oxygenases including the HIF hydroxylases [4]. Results are shown for U2OS cells 
(Figure 1 b and c). As expected we observed robust observed robust upregulation of HIF-1alpha by 
immunoblot analysis that equalled or exceeded that achieved by the hypoxic exposure (Figure 1b). 
RT-Q-PCR analysis of JMJD1 and JMJD2 transcripts demonstrated substantial upregulation, the 
pattern being closely similar to that observed for hypoxia (Figure 1c). JMJD1A, JMJD2B and 
JMJD2C were again the most strongly induced genes, with responses to DMOG exceeding 20-fold 
induction for JMJD2B (Figure 1c). Assay of effects on endogenous JMJD protein levels is limited by 
the availability of appropriate antibodies. Nevertheless we were able to confirm that JMJD1A protein 
levels were increased significantly; both under hypoxia and with the addition of DMOG (Figure 1d). 
 
To test the involvement of HIF in these responses we next analysed cells bearing different genetic 
manipulations of the HIF system. First, we analysed changes in expression in response to normoxic 
overexpression of HIF-1alpha, using the C29 cell line, a stable U2OS transfectant bearing a 
doxycycline-inducible HIF-1alpha transgene [20]. Exposure of normoxic C29 cells to doxycycline 
resulted in sustained induction of HIF-1alpha (Figure 2a) that was associated with sustained, though 
more moderate induction of JMJD1A, JMJD2B and JMJD2C over the 48 hour period of doxycycline 
exposure (Figure 2b).  
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We next analysed responses in R38 cells, a VHL-defective RCC (RCC4) transfectant that re-
expresses a doxycycline-inducible HA-tagged wild-type VHL transgene [21]. In keeping with base-
line VHL-defective status, R38 cells expressed increased levels of HIF-1alpha sub-units in normoxia, 
whereas treatment with doxycycline over a 48 hour period resulted in sustained expression of HA-
VHL and reduction of HIF-1alpha (Figure 2c). Consistent with a role for HIF in the regulation of 
JMJD1 and JMJD2 gene families, downregulation of HIF-1alpha was associated with downregulation 
of JMJD1 and JMJD2 transcripts in a pattern that was the inverse of that observed for hypoxia and 
induction of HIF-1alpha in that JMJD1A, JMJD2B and JMJD2C showed the greatest reduction in 
expression (Figure 2d). 
 
Finally we tested the role of HIF-1alpha and HIF-2alpha isoforms using siRNA mediated knockdown 
in hypoxic MCF7 cells. As indicated in Figure 2e MCF7 cells express both HIF-1alpha and HIF-
2alpha; siRNAs directed against each HIF-alpha isoform, but not control siRNA, resulted in specific 
knock-down of the target. Analysis of JMJD transcripts from hypoxic cells indicated that siRNA 
directed against HIF-1alpha substantially reduced expression of JMJD1A, JMJD2B and JMJD2C, 
whereas siRNA directed against HIF-2alpha had essentially no effect (Figure 2f). 
 
Binding of HIF-alpha subunits to the promoters of JMJD1A and JMJD2B  
 
Taken together, these results indicate that induction of JMJD1A, JMJD2B and JMJD2C by hypoxia is 
mediated directly or indirectly by HIF-1alpha. Direct transcriptional activation at HIF target gene loci 
is mediated by binding of the HIF complex to hypoxia response elements containing the core motif 
RCGTG [1]. To identify such sites at loci encoding JMJD1 and JMJD2 family members, we searched 
the March 2006 Human Genome assembly (http://genome.ucsc.edu/) in silico for HIF binding sites 
that were highly conserved amongst mammalian species, within the regions (-5 to + 0.5kB) of the 
assigned transcriptional start site. Three potential HIF binding sites within these regions were 
identified in the three members that were demonstrated to be induced in hypoxia by HIF-1alpha 
(JMJD1A and JMJD2B, C) and no such sites in the remaining four members (JMJD1B, C and 
JMJD2A ,D), suggesting that the three hypoxia inducible genes might be direct target genes.  
 
To test whether these loci did indeed bind HIF-alpha subunits we performed ChIP assays using anti-
HIF-1alpha antibodies (PM14) or anti-HIF-2alpha antibodies (PM9) or control pre-immune sera, and 
carried out RT-Q-PCR analysis of precipitated DNA using primers designed to amplify each of the 
predicted HREs. To provide further controls, primers were also designed to a region of the JMJD1A 
promoter region that does contain an HRE and to the JMJD2A promoter that does not contain an HRE 
and did not exhibit regulation by HIF or hypoxia in the transcript analyses. Significant and 
reproducible enrichment of DNA containing HREs at the JMJD1A and JMJD2B loci was observed 
with both anti-HIF-1alpha and anti-HIF-2alpha antibodies (Table 2). More moderate enrichment was 
observed at the JMJD2C locus with anti HIF-1alpha but not anti HIF-2alpha. No enrichment of the 
non-HRE containing amplicons was detected with either antibody. 
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Discussion 
 
This study has defined genes encoding Jumonji-domain containing 2OG dependent oxygenases, with 
histone demethylase activity, as a new class of HIF-responsive hypoxia-inducible genes. We focused 
our analysis on two groups of closely related genes; those encoding JMJD1A-C proteins that contain 
only the catalytic JmjC domain, and JMJD2A-D that contain both JmjN and JmjC domains (as well 
Tudor and plant homology domains in the case of JMJD2A-C) [18]. Among these families, we 
observed consistent patterns of regulation with genes encoding JMJD1A, JMJD2B and JMJD2C, but 
not other members being inducible by hypoxia. Though JMJD1A and JMJD2B showed particularly 
striking regulation by hypoxia, prompting us to focus on the JMJD groups, a range of other genes 
encoding human 2OG dependent oxygenases showed hypoxia-inducible behaviour in the MCF7 cell 
gene expression array (Table1). Consistent with previous reports regulation by hypoxia was observed 
for the HIF hydroxylases PHD2 and PHD3 [4, 16, 17], and for the procollagen prolyl and lysyl 
hydroxylases (C-P4H and PLOD groups) [14, 15]. However, and also consistent with reported data [4, 
20], PHD1 and FIH (factor inhibiting HIF, an asparaginyl hydroxylase, which like PHD2 and PHD3 
are proposed to act as sensing enzymes in the HIF system, are not, or much less significantly, 
regulated by hypoxia. Modest regulation by hypoxia was also noted in the MCF7 cell gene expression 
array for other classes of Jumonji-domain containing proteins including members of the JARID and 
JTR groups. Several of these proteins also have histone demethylase activity so that it is possible that 
regulation by hypoxia extends more widely across this group of enzymes.  
Dynamic control of histone methylation status is proposed to regulate chromatin assembly and gene 
expression [18, 26]. Histone lysyl methylation is currently known to occur on histone 3, (H3), at K4, 
K9, K27, K36 and K79, and on histone 4 (H4) at K20; each site potentially existing as mono-(me1), 
di-(me2), or tri-(me3) methylated forms associated with distinct biological functions [18, 26-28]. 
Though the patterns of substrate specificity are as yet incompletely defined, some HDMs are reported 
to be highly site specific. For instance JMJD1A has so far been shown to exhibit demethylation 
activity on H3K9me1 and H3K9me2 but not H3K9me3 [29]; JMJD2B exhibits poor enzyme activity 
in vitro but has been demonstrated to specifically reduce H3K9me3 when overexpressed in cells [30]; 
JMJD2C exhibits demethylation activity on both H3K9me3 and H3K36me3 [31]. Interestingly 
specific HDMs have been associated with the regulation of particular transcriptional pathways. For 
instance JMJD1A is associated with the androgen receptor (AR) and has been shown to positively 
regulate certain AR target genes [29, 32]. In embryonic stem cells JMJD1A and JMJD2C enhance the 
expression of genes associated with self-renewal and are targets of the transcription factor Oct4 [33]. 
This suggests that expression levels of specific histone demethylases may themselves be regulated as 
component of physiological control systems directing patterns of gene expression. Interestingly, Oct-4 
has itself been identified as gene responding specifically to HIF-2alpha in embryonic stems cells [34]. 
Our studies, in a range of different cells lines, have identified a different and more direct connection 
between histone demethylases and the HIF system. Pharmacological and genetic analyses 
demonstrated functional control of particular JMJD-encoding genes by HIF, specifically by HIF-
1alpha, whilst ChIP assays defined HIF-alpha binding sites in the promoters of these hypoxia-
inducible genes. Interestingly, whilst ChIP assays indicated that both HIF-1alpha and HIF-2alpha 
bound to promoter sequences, siRNA-mediated suppression suggested that HIF-1alpha, but not HIF-
2alpha, was responsible for induction of JMJD1A and JMJD2B in hypoxia, even though both HIF-
alpha isoforms were induced under the experimental conditions. Such behaviour has been noted at 
certain other HIF target gene loci [22, 35], and is consistent with recent data indicating that HIF-alpha 
isoform transcriptional selectivity is mediated by post-DNA binding mechanisms conveyed by 
sequences distal to the DNA binding and dimerization domains [24, 35]. The nature of these 
mechanisms, together with the reasons why endogenous HIF-2alpha appears transcriptionally inactive 
at many loci, is incompletely understood, though evidence has been provided for the existence of a 
titratable repressor that limits HIF-2alpha activity in many cell types [35]. 
Although hypoxia has long been recognized to have major effects on genome integrity, gene 
expression and cell differentiation that likely involve epigenetic controls, detailed analyses of hypoxic 
effects on epigenetic modification of DNA and histones have so far been limited. Hypoxia, has, 
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however been noted to alter levels of both histone acetylation and histone methylation at certain sites 
[36, 37]. A recent study demonstrated that changes in both histone methyl transferase and histone 
demethylase activity contributed to changes in global H3K9 methylation status in response to hypoxic 
stress and focused on the upregulation of histone methyl transferase G9a in hypoxia by both HIF-
dependent and HIF-independent mechanisms [38].  
The current evidence for direct regulation of genes encoding specific histone demethylases by HIF-
1alpha suggests another means by which activation of the HIF pathway may contribute to the 
modulation of histone marks and gene expression profiles in hypoxic cells. Given the existence of 
several different mechanisms by which HIF and hypoxia itself may alter histone methylation, the 
difficulty of separating these effects accurately, and uncertainties regarding the extent to which 
transcriptional upregulation of JMJDs is reflected in biological activity, it is currently difficult to 
predict effects of our findings on overall cellular demethylase activity. Since the JMJD1 and JMJD2 
enzymes are 2OG dependent oxygenases that have an absolute requirement for dioxygen as co-
substrate it could be argued that any increases in enzyme abundance in hypoxia simply compensate 
for reduced activity. However, given the specificity of the HIF-mediated hypoxia-inducible response 
for particular histone lysyl demethylases with different methyl-lysyl substrate preferences, and 
different biological effects at particular transcriptional loci, this appears unlikely. Rather, we propose 
that this new class of HIF transcriptional target adds another level of control that shapes the 
transcriptional response to hypoxia. Our findings raise interesting questions as to whether the 
hypoxia-inducible histone demethylases are specifically associated with the HIF transcriptional 
complex, or with specific classes of hypoxia-inducible target gene loci, and if so how they function to 
modulate patterns of gene expression under conditions of varying oxygen availability.  
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Table Legends 
 
Table 1. Hypoxia up-regulates mRNA expression of selected known and potential human 2OG-
dependent oxygenases.  
Relative changes in expression levels upon exposure to hypoxia or treatment with DMOG (mean of 3 
biological replicates) compiled from data deposited in association with [10] at 
http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE3188. 2OG-dependent oxygenases are 
grouped by homology, and assigned according to HGNC (HUGO Gene Nomenclature Committee). 
NCBI GeneIDs are also given. For known catalytic functions and substrates see references in [28]; 
note the correct physiological substrate(s) may differ from those with which activity has been shown 
in vitro. Names given to each group reflect known or proposed functional assignments associated with 
the 2OG oxygenase and, in some cases, other distinct domains. Abbreviations are as follows: EGFH, 
epidermal growth factor aspartate/asparaginyl hydroxylase; C-P3H, collagen prolyl 3-hydroxylase; 
PHD, prolyl hydroxylase domain; OGFOD, 2OG and iron-dependent oxygenase domain; C-P4H, pro-
collagen prolyl 4-hydroxylase; PLOD, pro-collagen lysyl oxygenase domain; JmjC, C-terminal 
Jumonji-domain; JTR, Jumonji and tetratricopeptide repeat containing; JARID, Jumonji, AT rich 
interactive domain; JMJD1/2, Jumonji domain containing 1/2; JFBXL, Jumonji and F-box and 
leucine-rich repeat containing; JPHF, Jumonji and PHD finger containing; ALKBH, alkB alkylation 
repair homolog (E .coli); FTO, fat mass and obesity associated; PHYH (PAHX), phytanoyl-CoA 2-
hydroxylase; CAS-like, clavaminic acid synthase-like. HGNC official full names of genes are given 
(common names italicized in brackets); abbreviations as above or as follows: ASPH, aspartate beta-
hydroxylase; ASPHD1/2, aspartate beta-hydroxylase domain containing 1/2; LEPRE, leucine proline-
enriched proteoglycan (leprecan); LEPREL1/2, leprecan-like 1/2; EGLN1/2/3, egl nine homolog 1/2/3 
(C. elegans); P4H-TM, prolyl 4-hydroxylase transmembrane domain; P4HA1/2/3, procollagen-
proline, 2OG 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide I/II/III; JMJD4/5/6, jumonji 
domain containing 4/5/6; HSPBAP1, HSPB (heat shock 27kDa) associated protein 1; HIF1AN, 
hypoxia-inducible factor 1, alpha subunit inhibitor (FIH, factor inhibiting HIF); C2orf60, 
chromosome 2 open reading frame 60; MINA, MYC induced nuclear antigen; C14orf169, 
chromosome 14 open reading frame 169; UTX, ubiquitously transcribed tetratricopeptide repeat, X 
chromosome; UTY, ubiquitously transcribed tetratricopeptide repeat gene, Y-linked; JMJD3, Jumonji 
domain containing 3; HR, hairless homolog (mouse); JHDM2/3, Jumonji C domain containing 
histone demethylase 2/3; FBXL10/11, F-box and leucine-rich repeat protein 10/11; PHF2/8, PHD 
finger protein 2/8; JHDM1D, Jumonji C domain containing histone demethylase 1 homolog D (S. 
cerevisiae); TMLHE, trimethyllysine hydroxylase, epsilon; BBOX1 (GBBH), butyrobetaine 
(gamma), 2OG dioxygenase (gamma-butyrobetaine hydroxylase) 1; *, genes not assigned by HGNC. 
Other abbreviations; ARD, ankyrin repeat domain; me, methylated; meA, methyladenosine; meC, 
methylcytidine; meT, methylthymidine. 
 
 
Table 2: ChIP assays of DNA at hypoxia responsive promoters. 
 
The core sequence and position related to the transcriptional start site is given for each HRE. Data are 
the mean (range) of the fold enrichment of chromatin precipitated DNA. The means and ranges were 
determined from 3 biological replicates, each assayed in triplicate. 
*significant enrichment p<0.01 
#significant enrichment p<0.05 
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Figure 1: 
 
A: Hypoxic induction of JMJD1A-C and JMJD2A-D mRNA in U2OS, MCF7, HeLa, IMR32 and 
HL60 cells. Data is the fold increase in mRNA in cells cultured in hypoxia (0.5% O2) related to 
parallel cultures in normoxia (21% O2). JMJD1A and 2B are significantly upregulated (p<0.01) in 
each cell type. Significant hypoxic induction of JMJD2C (p<0.01) was observed in U2OS, HeLa and 
IMR32 cells. Y-error bars indicate one standard deviation calculated from 3 biological replicates, each 
assayed in triplicate. 
 
B: Immunoblot demonstrating increase of HIF-1alpha protein accumulation under hypoxia (lane 2), or 
with addition of either DFO (lane 4) or DMOG (lane 5). Protein loading is indicated by β-actin 
(bottom panel). 
 
C: Effect of DFO and DMOG treatment on expression of JMJD1 and JMJD2 transcripts in U2OS 
cells. JMJD1A, 2B and 2C mRNAs are significantly elevated by both stimuli (p<0.01); JMJD1C 
mRNA was significantly increased by DMOG treatment (p<0.01) but not after DFO treatment. Y-
error bars indicate one standard deviation calculated from 3 biological replicates, each assayed in 
triplicate.  
 
D: Effect of hypoxia and DMOG on expression of JMJD1A protein in U2OS cells. Immunoblot 
demonstrates increase of HIF-1 alpha (middle panel) and JMJD1A (top panel) protein under hypoxia 
(lane 2) or with the addition of DMOG (lane 3). Protein loading is indicated by β-actin (bottom 
panel). 
 
 
Figure 2: 
 
A and B: Inducible HIF-1alpha overexpression in U2OS cells. Immunoblot (A) demonstrating 
increased expression of HIF-1alpha protein at 24 hours (lane 2) and 48 hours (lane 3) after 
doxycycline administration. RT-Q-PCR analysis (B) shows a significant (p<0.01) increase in 
JMJD1A, 2B and 2C mRNA after doxycycline administration.  
 
C and D Expression of VHL in RCC4 cells. Immunoblot (C) demonstrates reduction of HIF-1alpha 
protein at 24 hours (lane 2) and absence of HIF-1alpha protein at 48 hours (lane 3). RT-Q-PCR 
analysis (D) shows significant (p<0.01) decrease in JMJD1A, 2B and 2C mRNA by 48 hours after 
doxycycline administration.  
 
E and F Effect of HIF-1alpha and HIF-2alpha siRNA. Immunoblot (E) demonstrates effects on HIF-
alpha proteins. siRNA against Drosophila HIF (dH, lane 1) had no effect on HIF-1alpha or HIF-
2alpha protein levels, whereas siRNA to HIF-1alpha and HIF-2alpha each abolish protein levels of 
their specific target genes (lanes 2-3). β-actin was used as a control to assay gel loading (bottom 
panel). RT-Q-PCR analysis (F) shows significant (p<0.01) reduction in hypoxic induction of 
JMJD1A, 2B and 2C mRNAs by HIF-1alpha directed siRNA.  
 
Y-error bars indicate one standard deviation calculated from 3 biological replicates, each assayed in 
triplicate. 
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Table 1: 
 
Group Symbol Hypoxia DMOG Catalytic function (proposed) & substrate GeneID 
ASPH (EGFH) 3.04 3.22 444 
ASPHD1 (EGFHD1) 1.34 0.98 253982 
EGFH 
ASPHD2 (EGFHD2) 0.87 1.03 
Asn/Asp 3R-hydroxylation (EGF-domains) 
57168 
LEPRE1 1.20 1.12 64175 
LEPREL1 1.04 1.00 55214 
LEPREL2 1.15 1.01 
Pro 3S-hydroxylation (collagen) 
10536 
C-P3H 
* (FLJ22222) 1.06 1.09  79701 
EGLN3 (PHD3) 15.29 19.47 112399 
EGLN1 (PHD2) 3.66 5.95 54583 
PHD 
EGLN2 (PHD1) 0.69 0.86 
Pro 4R-hydroxylation (HIF-alpha) 
112398 
* (P4H-TM) 1.16 0.90  54681 OGFOD-
only OGFOD1 0.56 0.65  55239 
P4HA1  5.36 7.56 5033 
P4HA2 7.47 9.85 8974 
C-P4H 
P4HA3 0.96 0.98 
Pro 4R-hydroxylation (pro-collagen) 
283208 
PLOD1 2.19 1.49 5351 
PLOD2 2.63 3.40 5352 
PLOD 
PLOD3 1.27 0.90 
Lys 5R-hydroxylation (pro-collagen) 
8985 
JMJD4 0.91 0.91  65094 
JMJD5 0.97 0.95  79831 
JMJD6 1.19 1.45 Arg(me) demethylation (histones H3R2/H4R3) 23210 
HSPBAP1 1.09 0.90  79663 
HIF1AN (FIH) 0.91 0.96 Asn 3S-hydroxylation (HIF-alpha/ARDs) 55662 
C2orf60 0.70 0.81  129450 
* (LOC8681) 0.68 1.08  8681 
MINA 0.55 0.58  84864 
JmjC-
domain 
C14orf169 0.37 0.40  79697 
UTX 1.36 1.01 7403 
UTY 1.62 1.18 7404 
JTR 
JMJD3 1.64 1.58 
Lys(me) demethylation (histone H3K27) 
23135 
JARID1A 1.53 1.55 5927 
JARID1B 1.72 1.85 10765 
JARID1C 1.21 1.39 8242 
JARID1D 1.03 1.02 
Lys(me) demethylation (histone H3K4) 
8284 
JARID 
JARID2 1.20 1.03  3720 
HR 1.50 1.65  55806 
JMJD1A (JHDM2A) 7.01 9.80 55818 
JMJD1B (JHDM2B) 1.07 1.08 51780 
JMJD1 
JMJD1C (JHDM2C) 1.96 1.93 
Lys(me) demethylation (histone H3K9) 
221037 
JMJD2A (JHDM3A) 1.14 0.91 9682 
JMJD2B (JHDM3B) 3.04 2.62 23030 
JMJD2C (JHDM3C) 1.40 1.44 23081 
JMJD2 
JMJD2D (JHDM3D) 1.23 1.01 
Lys(me) demethylation (histone H3K9/K36) 
55693 
FBXL11 1.49 1.33 22992 JFBXL 
FBXL10 0.93 0.83 
Lys(me) demethylation (histone H3K36) 
84678 
PHF2 0.79 0.77  5253 
PHF8 1.05 1.01  23133 
JPHF 
JHDM1D 1.38 1.89  80853 
ALKBH1 0.76 0.99  8846 
ALKBH2 0.95 0.75 121642 
ALKBH3 0.98 0.94 
1-meA/3-meC demethylation (DNA/RNA) 
221120 
ALKBH4 0.96 1.15  54784 
ALKBH5 1.3 1.48  54890 
ALKBH6 1.04 0.67  84964 
ALKBH7 1.07 0.95  84266 
ALKBH 
ALKBH8 0.89 0.82  91801 
FTO FTO 1.06 0.81 3-meT/1-meA/3-meC demethylation (DNA/RNA) 79068 
PHYH PHYH (PAHX) 1.26 1.04 threo 2-hydroxylation (phytanoyl-CoA) 5264 
TMLHE 1.03 1.01 5R-hydroxylation (trimethyllysine) 55217 CAS-like 
domain BBOX1 (GBBH) 1.04 0.96 3S-hydroxylation (γ-butyrobetaine) 8424 
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Table 2: 
 
 Enhancement (mean/range) Gene HRE (base pairs 
from mRNA start) anti-HIF-1alpha anti-HIF-2alpha pre-immune 
JMJD1A -598 ACGTG -594 *135 (113-161) *44 (26-76) 2.7 (1.1-3.1) 
JMJD1A --- 2.3 (0.8-3.7) 1.8 (1.1-3-1) 1.5 (0.5-2.9) 
JMJD2B -248 ACGTG -244 *72 (37-140) *117 (38-188) 1.9 (0.7-4.2) 
JMJD2C +290 ACGTG +294 #11.8 (3.0-46.2) 0.7 (0.2-2.1) 0.9 (0.3-2.6) 
JMJD2A --- 1.8 (1.4-2.3) 1.2 (0.5-3.2) 1.1 (0.5-1,8) 
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Figure 1 
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Figure 2 
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